Alan H.B. Wu

Dr. Wu is well established in the fields of clinical chemistry, toxicology, cardiac biomarkers and pharmacogenomics. He brings over 30 years of experience to the Truvian Scientific Advisory Board. Dr. Wu previously served as Assistant Professor of Pathology at the University of Texas Medical School, Houston and Associate Director of Clinical Chemistry at Hermann Hospital. He joined Harford Hospital in 1992 to become Director of the Chemistry and Toxicology Laboratories and became Professor of Laboratory Medicine and Adjunct Professor of Chemistry at the University of Connecticut Farmington and Storrs CT campuses, respectively. In 2004, he became Director of Chemistry and Toxicology at San Francisco General Hospital (SFGH) and Professor of Laboratory Medicine at the University of California, San Francisco (UCSF). There, he established the first Clinical Pharmacogenomics Laboratory at UCSF. Dr. Wu currently serves as the Chief of the Clinical Chemistry Laboratory at SFGH and the Chief of Clinical Pharmacogenomics Laboratory at UCSF.Dr. Wu has over 500 peer reviewed and non-peer reviewed publications, book chapters, and books, and hundreds of published abstracts. Since 1999, he has been Editor-in-Chief of Clinica Chimica Acta. He has been the director of COMACC-accredited clinical chemistry postdoctoral program in Texas, Connecticut, and California. He has received numerous awards from the American Association for Clinical Chemistry.